A. Tenorio

发表

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

M. Benatar, M. Tosun, M. Kurtoğlu, 2023, The Lancet Neurology.